| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/17/2013 | US20130017234 Implant modified with non-hydroxylated vitamin d precursors |
| 01/17/2013 | US20130017233 Tricalcium Phosphate Coarse Particle Compositions and Methods for Making the Same |
| 01/17/2013 | US20130017232 Synthetic bone grafts |
| 01/17/2013 | US20130017231 Composition for Forming a Temporary Intestinal Occlusion in a Mammal |
| 01/17/2013 | US20130017230 Jelly-form preparation and method for producing jelly-form preparation |
| 01/17/2013 | US20130017229 Active scaffolds for on-demand drug and cell delivery |
| 01/17/2013 | US20130017228 Methods and compositions for bone formation |
| 01/17/2013 | US20130017227 Wound healing compositions and associated methods |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | US20130017148 Systems for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/17/2013 | US20130017147 Targeting agent for tumor site |
| 01/17/2013 | US20130014758 Dry powder formulations |
| 01/17/2013 | CA2850089A1 Stable dosage forms of arterolane and piperaquine |
| 01/17/2013 | CA2841807A1 A new therapeutical composition containing apomorphine as active ingredient |
| 01/17/2013 | CA2841731A1 Nicotinamide compositions and the therapeutic use thereof |
| 01/17/2013 | CA2841632A1 Gel compositions of oxymetazoline and methods of use |
| 01/17/2013 | CA2841411A1 Use of xanthophyll carotenoids to improve visual performance and neural efficiency |
| 01/17/2013 | CA2841356A1 Parenteral norovirus vaccine formulations |
| 01/17/2013 | CA2841272A1 Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis |
| 01/17/2013 | CA2840831A1 Compressed gas aerosols with enhanced intensity and longevity of actives |
| 01/17/2013 | CA2840401A1 Process for the preparation of fluticasone propionate form 1 |
| 01/16/2013 | EP2546245A1 Antiprotozoal compound originating in coelenterata |
| 01/16/2013 | EP2545940A1 Parenteral compositions |
| 01/16/2013 | EP2545939A2 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| 01/16/2013 | EP2545937A1 Nanoemulsion vaccines |
| 01/16/2013 | EP2545926A1 Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 01/16/2013 | EP2545912A1 Ketoprofen-containing aqueous adhesive skin patch |
| 01/16/2013 | EP2545908A1 Medium for microbubbles or microparticles and preparation thereof |
| 01/16/2013 | EP2545907A1 Aqueous wet granulation process for cross-linked polyallylamine polymers |
| 01/16/2013 | EP2545906A1 Color-codes and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 01/16/2013 | EP2545905A1 A new therapeutical composition containing apomorphine as active ingredient |
| 01/16/2013 | EP2545904A1 Jelly-form preparation and method for producing jelly-form preparation |
| 01/16/2013 | EP2545891A1 Patch package |
| 01/16/2013 | EP2545833A2 Foamed cleanser with suspended particles, a method of producing same and a dispenser thereof |
| 01/16/2013 | EP2545776A2 Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
| 01/16/2013 | EP2545044A1 Dabigatran etexilate-containing pharmaceutical composition |
| 01/16/2013 | EP2545025A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | EP2544887A1 A device for the manufacture of a dosage form with a hole and method of manufacture |
| 01/16/2013 | EP2544733A2 Electro-osmotic pumps, systems, methods, and compositions |
| 01/16/2013 | EP2544723A2 Compositions for colon lavage and methods of making and using same |
| 01/16/2013 | EP2544721A1 Non-aqueous high concentration reduced viscosity suspension formulations |
| 01/16/2013 | EP2544699A2 A novel method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer |
| 01/16/2013 | EP2544695A1 Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
| 01/16/2013 | EP2544694A2 A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies that inhibit c5 interactions with properdin |
| 01/16/2013 | EP2544692A1 Use of tigecycline for treatment of cancer |
| 01/16/2013 | EP2544689A2 Solid compositions |
| 01/16/2013 | EP2544685A2 Solid pharmaceutical composition, comprising donepezil hydrochloride of the crystalline polymorphous form i |
| 01/16/2013 | EP2544670A1 Nanostructure-enhanced platelet binding and hemostatic materials and structures |
| 01/16/2013 | EP2544669A1 Adhesive patch for therapeutic agent delivery |
| 01/16/2013 | EP2544668A2 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 01/16/2013 | EP2544667A1 Alcohol resistant enteric pharmaceutical compositions |
| 01/16/2013 | EP2544666A2 Gastroretentive, extended release composition of therapeutic agent |
| 01/16/2013 | EP2544665A1 Quick dissolve nutritional powder |
| 01/16/2013 | EP2544664A1 Supported biologically active compounds |
| 01/16/2013 | EP2544663A2 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 01/16/2013 | EP2544662A2 Foamable formulation |
| 01/16/2013 | EP2544661A2 Micelle compositions and process for the preparation thereof |
| 01/16/2013 | EP2544660A2 Rifaximin ready-to-use suspension |
| 01/16/2013 | EP2544659A2 Highly permeating terbinafine formulation for treating onychomycosis |
| 01/16/2013 | EP2544658A2 Injectable drug delivery system |
| 01/16/2013 | EP2544657A2 The use of amisulpride as an anti-emetic |
| 01/16/2013 | EP2544654A2 Dual function product |
| 01/16/2013 | EP2544653A2 Structured non-aqueous gel-form carrier composition |
| 01/16/2013 | EP2544546A1 Food grade dry film coating composition and methods of making and using the same |
| 01/16/2013 | EP2544537A1 Parenteral formulations of macrolide antibiotics |
| 01/16/2013 | EP2544533A1 Triggered cargo release from nanoparticle stabilized liposomes |
| 01/16/2013 | EP2014304B1 Colon cleansing compositions |
| 01/16/2013 | CN202666024U Kidney channel Chinese medicine injecta and package of the same |
| 01/16/2013 | CN202666023U Osteopathy treatment combined type medicine patch |
| 01/16/2013 | CN202666019U Microcapsule containing nanometer metal liquid |
| 01/16/2013 | CN1925867B Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof |
| 01/16/2013 | CN1878541B Microparticles comprising somatostatin analogues |
| 01/16/2013 | CN1863513B Abuse-proofed dosage form |
| 01/16/2013 | CN102884181A Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
| 01/16/2013 | CN102884037A Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | CN102883758A High shear application in medical therapy |
| 01/16/2013 | CN102883735A Transdermal administration of peptides |
| 01/16/2013 | CN102883730A Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 01/16/2013 | CN102883726A Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2 -thienylmethylbenzene derivatives as inhibitors of SGLT |
| 01/16/2013 | CN102883725A Topical pharmaceutical compositions comprising mometasone furoate |
| 01/16/2013 | CN102883715A Chitosan-containing protective composition |
| 01/16/2013 | CN102883714A Indigestible polymer: starch acetate-based film coatings for colon targeting |
| 01/16/2013 | CN102883713A Alcohol-resistant formulations |
| 01/16/2013 | CN102883712A Gastro-resistant enzyme pharmaceutical compositions |
| 01/16/2013 | CN102883711A Pharmaceutical formulations comprising pioglitazone and linagliptin |
| 01/16/2013 | CN102883710A Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same |
| 01/16/2013 | CN102883709A Combinations of preservative compositions for ophthalmic formulations |
| 01/16/2013 | CN102883708A Combinations of preservatives for ophthalmic compositions |
| 01/16/2013 | CN102883705A Personal care formulations containing alkyl ketal esters and methods of manufacture |
| 01/16/2013 | CN102883701A Foam formulations containing at least one triterpenoid |
| 01/16/2013 | CN102876697A Nano cationic liposome carrying FL gene recombinant plastid, and preparation method and application of nano cationic liposome |
| 01/16/2013 | CN102875848A Biological composite material and capsule prepared from biological composite material |
| 01/16/2013 | CN102875689A Preparation method and application of ophiopogon japonicus polysaccharide |
| 01/16/2013 | CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein |
| 01/16/2013 | CN102875575A Cefodizime sodium compound and preparation thereof |
| 01/16/2013 | CN102875472A Econazole nitrate compound crystal and preparation method and drug composition thereof |
| 01/16/2013 | CN102872526A Microneedle devices and microneedle delivery apparatus |
| 01/16/2013 | CN102872462A Ambroxol hydrochloride composition and preparation thereof |
| 01/16/2013 | CN102872453A Vaginal rejuvenation gel and preparation method thereof |
| 01/16/2013 | CN102872451A Liquid composition of factor vii polypeptides |